Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. PreveCeutical Medical Inc.
  6. News
  7. Summary
    18H   CA74141E1043

PREVECEUTICAL MEDICAL INC.

(18H)
Delayed Deutsche Boerse AG  -  02:00:17 2023-01-27 am EST
0.0200 EUR   -15.97%
01/26PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
AQ
01/24PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds
AQ
01/18PreveCeutical - Dynorphin Peptides and Uses Thereof Patent Update and Officer Update
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about PREVECEUTICAL MEDICAL INC.
01/26PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
AQ
01/24PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds
AQ
01/18PreveCeutical - Dynorphin Peptides and Uses Thereof Patent Update and Officer Update
AQ
01/12PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
NE
01/12Preveceutical Medical : Enters into License Option Agreement with Endosane Pharmaceuticals
PU
01/09PreveCeutical Medical Inc. Signs Sol-Gel License Agreement with Its Subsidiary PreveCeu..
CI
2022PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022Preveceutical Medical : files Application for D-amino Acid Peptides
PU
2022Preveceutical Medical : Announces Conversion of Debt
PU
2022Appointment of Kathleen Rotika to PreveCeutical's Board of Directors
AQ
2022Preveceutical Medical Inc. Announces Appointment of Kathleen Rotika to Board of Directo..
CI
2022PreveCeutical Medical Inc. Announces Resignation of Sachin Nanavati as A Member of the ..
CI
2022Appointment of Sachin Nanavati to PreveCeutical's Board of Directors
AQ
2022PreveCeutical Medical Inc. Appoints Mr. Sachin Nanavati to Board of Directors
CI
2022Preveceutical Medical : Md&a
PU
More most relevant news
All news about PREVECEUTICAL MEDICAL INC.
01/26PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
AQ
01/24PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds
AQ
01/18PreveCeutical - Dynorphin Peptides and Uses Thereof Patent Update and Officer Update
AQ
01/12PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
NE
01/12Preveceutical Medical : Enters into License Option Agreement with Endosane Pharmaceuticals
PU
01/09PreveCeutical Medical Inc. Signs Sol-Gel License Agreement with Its Subsidiary PreveCeu..
CI
2022PreveCeutical Medical Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2022Preveceutical Medical : files Application for D-amino Acid Peptides
PU
2022Preveceutical Medical : Announces Conversion of Debt
PU
2022Appointment of Kathleen Rotika to PreveCeutical's Board of Directors
AQ
More news
News in other languages on PREVECEUTICAL MEDICAL INC.
01/09PreveCeutical Medical Inc. signe un accord de licence Sol-Gel avec sa filiale PreveCeut..
2022PreveCeutical Medical Inc. annonce ses résultats pour le troisième trimestre et les neu..
2022Preveceutical Medical Inc. annonce la nomination de Kathleen Rotika au conseil d'admini..
2022PreveCeutical Medical Inc. annonce la démission de Sachin Nanavati en tant que membre d..
2022PreveCeutical Medical Inc. nomme M. Sachin Nanavati au Conseil d'administration
2022PreveCeutical Medical Inc. annonce ses résultats pour le deuxième trimestre et le semes..
2022PreveCeutical Medical Inc. annonce ses résultats pour le premier trimestre clos le 31 m..
2022PreveCeutical Medical Inc. annonce des changements de direction
2022PreveCeutical Medical Inc. Le vérificateur remet en question la continuité de l'entrepr..
2022PreveCeutical Medical Inc. annonce ses résultats pour l'année complète se terminant le ..
More news
Press releases
01/26PreveCeutical - Australian Patent Granted for Disulfide Bond Containing Compounds
AQ
01/24PreveCeutical - Background IP, US Patent Granted Disulfide Bond Containing Compounds
AQ
01/18PreveCeutical - Dynorphin Peptides and Uses Thereof Patent Update and Officer Update
AQ
01/12PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
NE
01/12Preveceutical Medical : Enters into License Option Agreement with Endosane Pharmaceuticals
PU
More press releases
Upcoming event on PREVECEUTICAL MEDICAL INC.